Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.
about
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunityEvolution of animal models in cancer vaccine developmentSerum anti-BPAG1 auto-antibody is a novel marker for human melanomaOpportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunityAnti-HER2 vaccines: new prospects for breast cancer therapyCryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity.Breaking tolerance in transgenic mice expressing the human TSH receptor A-subunit: thyroiditis, epitope spreading and adjuvant as a 'double edged sword'.Partial depletion of regulatory T cells does not influence the inflammation caused by high dose hemi-body irradiationDepletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunityToll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice.Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors.Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA.Effective anti-neu-initiated antitumor responses require the complex role of CD4+ T cells.DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies.Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice.Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice.CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases.The "A, B and C" of Her-2 DNA vaccine development.Regulatory T cells and human diseaseTumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells.Opportunistic autoimmune disorders: from immunotherapy to immune dysregulationTumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity.Anti-HER2/Neu passive-aggressive immunotherapy.Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.Acceleration of tumor growth due to dysfunction in M1 macrophages and enhanced angiogenesis in an animal model of autoimmune disease.CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge.A novel H2A-E+ transgenic model susceptible to human but not mouse thyroglobulin-induced autoimmune thyroiditis: identification of mouse pathogenic epitopes.Controversies on autoimmunity and prognosis in cancer.Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia
P2860
Q26852013-87E32A77-CE1C-4BC2-875A-5871E419D15FQ28080739-CAF89228-BD4A-434C-B0B3-D74EA628DC75Q30982790-2A6898B2-E665-4A3B-B420-2F76B94CA82AQ33658400-EFBB3EA7-7A4A-4945-AAD5-C2B52F9E0594Q34073138-6EA3C939-6463-4CDB-BB14-F1BFE194707BQ34105959-E3AF0E55-A6B1-478E-A8FC-FF54B1DD6FE4Q34288183-881112D5-11C4-47A0-937E-A3AE5C465A8DQ34412076-D464727D-0131-49EC-B9E2-17ED82242FC0Q34586998-3DBD517E-8E5C-49C6-8148-7F0686B0F915Q34984596-9A3C2BBF-0945-48A6-B6A9-CC13B7782BEFQ35005601-6F7EF284-5252-4255-BFE3-8774D098B0FEQ35201826-B0B90A09-E0FD-4DFE-91CE-75CB585DD6DCQ36070101-F754AEDC-A7D9-4503-AFB8-61032E1874AEQ36698273-07CC382A-364D-462C-963F-050257BBA57BQ36924836-E42ADA37-2C23-4E89-91F4-F4A099BB79A2Q36984725-736DBD83-2DC3-4424-A1CA-FD60AED44626Q37000546-EDD89F32-7182-430B-839E-71E6F9D2F33AQ37036281-6BD311B5-E697-4FDE-8EEF-AEFE810FA3E3Q37082777-450D820A-25A1-4FEE-9B2D-DA2BBE7CF586Q37084243-9E188A05-629D-412D-8E10-FC67CB6173BDQ37101255-30AB2A6C-005F-4B18-99F1-4C83A696279EQ37136949-C0BBFE20-9DB2-47FC-8471-56BCE9DFF56AQ37274049-B11F3797-6620-49B6-B462-5355A565DDCBQ37323685-B476B6FC-0091-4D1A-BACF-DA96129BB81AQ37388149-42479B56-CDB9-4161-BE86-7C116FEE5746Q37404065-29E28EE6-7EA9-476E-8504-AB9CB096C8E8Q37520219-71B34255-F377-4ACE-A1F7-EC47119FBA57Q37605244-1006901F-006D-4088-A25A-F14EEBEFD0F9Q37613262-650EDE53-4744-4B8E-831D-443D836995BAQ38799583-DB4C102C-6ACF-4A41-A641-F3545B22AD29Q40217683-09AC750B-D792-43AD-BEA7-1C7083639D30Q40902210-748CA94D-118D-4666-9374-FD5F0A37ECB2Q43199466-A7144221-6EF9-40EB-8384-5423A169C241Q56901030-1D336C52-1354-4F25-9BA8-CAB1107F1605
P2860
Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Concurrent induction of antitu ...... gulatory T cell-depleted mice.
@en
Concurrent induction of antitu ...... gulatory T cell-depleted mice.
@nl
type
label
Concurrent induction of antitu ...... gulatory T cell-depleted mice.
@en
Concurrent induction of antitu ...... gulatory T cell-depleted mice.
@nl
prefLabel
Concurrent induction of antitu ...... gulatory T cell-depleted mice.
@en
Concurrent induction of antitu ...... gulatory T cell-depleted mice.
@nl
P2093
P1433
P1476
Concurrent induction of antitu ...... egulatory T cell-depleted mice
@en
P2093
Alvaro A Giraldo
Ghazwan Alsharabi
Jennifer B Jacob
John F Zielinski
K David Shim
Wei-Zen Wei
Yi-chi M Kong
P304
P356
10.1158/0008-5472.CAN-05-0934
P407
P50
P577
2005-09-01T00:00:00Z